NDC 55566-0302

Acthrel

Corticorelin Ovine Triflutate

Acthrel is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Ferring Pharmaceuticals Inc.. The primary component is Corticorelin Ovine Triflutate.

• Product ID: 55566-0302_4a343616-3896-4ae7-a840-6345b62250df
• NDC: 55566-0302
• Product Type: Human Prescription Drug
• Proprietary Name: Acthrel
• Generic Name: Corticorelin Ovine Triflutate
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 1996-05-23
• Marketing Category: BLA / NDA
• Application Number: BLA020162
• Labeler Name: Ferring Pharmaceuticals Inc.
• Substance Name: CORTICORELIN OVINE TRIFLUTATE
• Active Ingredient Strength: 100 ug/2mL
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 55566-0302-1

1 VIAL, GLASS in 1 CARTON (55566-0302-1) > 2 mL in 1 VIAL, GLASS

• Marketing Start Date: 1996-05-23
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 55566-0302-1 [55566030201]

Acthrel INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

• Marketing Category: BLA
• Application Number: BLA020162
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 1996-05-23

Drug Details

Active Ingredients

Ingredient	Strength
CORTICORELIN OVINE TRIFLUTATE	100 ug/2mL

OpenFDA Data

• SPL SET ID: 3c39dcea-d8f7-8594-01e6-24e8d6fa4d2f
• Manufacturer:
  • Ferring Pharmaceuticals Inc.
• UNII:
  • 56X54T817Q